|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02197 CLOVER BIO-B
Nominal 
2.100 +0.080 (+3.960%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (194,826) | (288,486) | (727,878) | (1,690,809) |
| Net Cash from / (used in) Investing Activities | -- | (12) | 3,168 | (6,161) | (37,506) |
| Net Cash from / (used in) Financing Activities | -- | 64,388 | (51,499) | (142,408) | 483,143 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (130,450) | (336,817) | (876,447) | (1,245,172) |
| Cash & Cash Equivalents at beginning of period | -- | 401,243 | 735,864 | 1,607,409 | 2,767,371 |
| Effect of Foreign Exchange Rate Changes | -- | (3,164) | 2,196 | 4,902 | 85,210 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 267,629 | 401,243 | 735,864 | 1,607,409 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 954,976 |
| %Change | -- |
| EPS / (LPS) | RMB 0.750 |
| NBV Per Share (¥) | RMB -0.617 |